-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia

Reuters·10/21/2026 22:09:01

Please log in to view news